Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Taiyo Pharmaceutical Industry

Taiyo Pharmaceutical Industry
1930 FOUNDED
M&A STATUS
M&A LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Manufacturer of pharmaceutical products. The company manufactures about 550 generic drugs in a variety of therapeutic areas and dosage forms.

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Parent Company
Teva Pharmaceutical Industries
Primary Office
  • 24-11 Taikou 1 Chome
  • Nakamura-ku
  • Nagoya, 453-0801
  • Japan

+81 000-000-0000

Taiyo Pharmaceutical Industry Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Taiyo Pharmaceutical Industry‘s full profile, request access.

Request full access to PitchBook

Taiyo Pharmaceutical Industry Executive Team (1)

Name Title Board
Seat
Contact
Info
Makoto Shimada President & Chief Executive Officer